REDS Banner Logo

Other REDS Related Publications

The R01-funded HTLV Outcomes Study (HOST) HTLV cohort study continued work begun under REDS



   

Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, Barbeau B, Mahieux R. Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 2009 Sep 17;114(12):2427-38.

Bartman MT, Kaidarova Z, Hirschkorn D, Sacher RA, Fridey J, Garratty G, Gibble J, Smith JW, Newman B, Yeo AE, Murphy EL, HTLV Outcomes Study (HOST) Investigators. Long-term increases in lymphocytes and platelets in human T-lymphotropic virus type II infection. Blood 2008; 112(10): 3995-4002

Kwaan N, Lee TH, Chafets DM, Nass C, Newman B, Smith J, Garratty G, Murphy EL, HTLV Outcomes Study (HOST) Investigators. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. J Infect Dis. 2006; 194: 1557-64.

Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D, HTLV Outcomes Study Investigators. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J Infect Dis. 2004; Aug 1;190(3):504-10.


Infectious Disease editorials/reviews that were based in part on REDS findings



   

Busch MP and Glynn SA. Using blood donor and transfusion recipient biospecimen repositories to address emerging blood safety concerns and advance infectious disease research: The NHLBI Biologic Specimen Repository. Journal of Infectious Diseases 2009; 199: 1564-1566.

Busch MP, Kleinman SH, Nemo G. Current and emerging infectious risks of blood transfusion. JAMA 2002; 289: 959-962


REDS-II XMRV working group

   

Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, Lo SC, Mikovitz JA, Switzer WM, Linnen JM, Busch MP for the Blood XMRV Scientific Research Working Group. The Blood Xenotropic Murine Leukemia Virus- Related Virus Scientific Working Group: mission, progress, and plans. Transfusion 2011; 51: 643-653

Simmons G, Glynn SA, Komaroff AL et al. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett J Jr, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA, Busch MP.Blood XMRV Scientific Research Working Group (SRWG) Failure to Confirm XMRV/MLVs in the Blood of Patients with Chronic Fatigue Syndrome: A Multi-laboratory Study. Science 2011; 33: 814-817


REDS-III HOME | ACCESSIBILITY | READERS & PLAYERS | SITE INDEX | OTHER SITES | PRIVACY STATEMENT | FOIA | CONTACT US | OIG

National Institutes of Health    Department of Health and Human Services    USA.gov